Trimedyne, Inc. announced financial results for the quarter and nine months ended June 30, 2018. For the quarter, the company reported revenue of $1,597,000 against $990,000 for the same period a year ago. Net income was $46,000 or $0.38 per share against net loss of $3,000 or $0.02 per share for the same period a year ago, is a considerable improvement, which was primarily the result of an increase of export sales revenue. For the nine months, the company reported revenue of $4,483,000 against $3,203,000 for the same period a year ago. Net income was $156,000 or $1.27 per share against net loss of $259,000 or $2.11 per share for the same period a year ago, is a considerable improvement, which was primarily the result of an increase of export sales revenue.